NCT03042793
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Department of Hematology, Universityhospital Herlev and Gentofte Herlev, Denmark
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,090 public trials
2,046 recruiting studies
Lymphoproliferative Disorders trial results
NCT00088205
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woolloongabba, Queensland, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Parkville, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Prahran, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Wodonga, Victoria, Australia
Completed
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
NCT01388335
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France
Completed
Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma
NCT01217229
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University, The Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- Mayo Clinic Rochester, Minnesota, United States
- Nebraska Medical Center Omaha, Nebraska, United States
NCT01858558
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT01854567
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +17 more
- Locations
-
- University of Miami Health System Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02812875
- Conditions
- Adenoma, Advanced Solid Tumors or Lymphomas, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Sarah Cannon Research Institute Sarasota, Florida, United States
- Northwestern University Chicago, Illinois, United States
NCT01269385
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00824265
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Novartis Investigative Site Boca Raton, Florida, United States
- Novartis Investigative Site Chicago, Illinois, United States
- Novartis Investigative Site Clinton, Maryland, United States
- Novartis Investigative Site Kansas City, Missouri, United States
NCT01636622
- Conditions
- Advanced Cancers, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States